Evidence map›Paper›PMID 30086702›Full record

ArticleBMC genetics2018

Transcriptomic population markers for human population discrimination.

P Daca-Roszak, M Swierniak, R Jaksik, T Tyszkiewicz, M Oczko-Wojciechowska, J Zebracka-Gala, B Jarzab, M Witt, E Zietkiewicz

Open access · diamondAbstract read
In one paragraph

Article in BMC genetics, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.4field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 2 countries.

P Daca-RoszakInstitute of Human Genetics, Polish Academy of Sciences, Strzeszynska 32, 60-479, Poznan, Poland.
M SwierniakMaria Sklodowska-Curie, Memorial Cancer Center and Institute of Oncology, Gliwice Branch, Gliwice, Poland.
R JaksikInstitute of Automatic Control, Silesian University of Technology, Gliwice, Poland.
T TyszkiewiczMaria Sklodowska-Curie, Memorial Cancer Center and Institute of Oncology, Gliwice Branch, Gliwice, Poland.
M Oczko-WojciechowskaMaria Sklodowska-Curie, Memorial Cancer Center and Institute of Oncology, Gliwice Branch, Gliwice, Poland.
J Zebracka-GalaMaria Sklodowska-Curie, Memorial Cancer Center and Institute of Oncology, Gliwice Branch, Gliwice, Poland.
B JarzabMaria Sklodowska-Curie, Memorial Cancer Center and Institute of Oncology, Gliwice Branch, Gliwice, Poland.
M WittInstitute of Human Genetics, Polish Academy of Sciences, Strzeszynska 32, 60-479, Poznan, Poland.
E ZietkiewiczInstitute of Human Genetics, Polish Academy of Sciences, Strzeszynska 32, 60-479, Poznan, Poland. ewa.zietkiewicz@igcz.poznan.pl.ORCID 0000-0003-2437-5088
The Maria Sklodowska-Curie National Research Institute of Oncology · PLInstitute of Human Genetics · PLMedical University of Warsaw · PLSilesian University of Technology · PL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundNumerous studies have demonstrated significant differences in the expression level across continental human populations. Most of published results were performed on B-cell lines materials examined under specific laboratory conditions, without further validation in a primary biological material. The goal of our study was to identify mRNA markers characterized by a significant and stable difference in the gene expression profile in Caucasian and Chinese populations, both in the commercially available B-lymphocyte cell lines and in the primary samples of the peripheral blood.

resultsThe preliminary selection of population-differentiating transcripts was based on Illumina expression microarray analysis of the representative group of ethnically-specified B-lymphocyte cell lines. Twenty genes with the inter-population difference in the mean expression characterized by the at least 1.5-fold change and FDR <  0.05 were identified. Subsequently, a two-step validation procedure was carried out. In the first step, a subset of selected population- differentiating transcripts was tested in the independent set of B-lymphocyte cell lines, using TLDA cards. Based on TLDA analysis, three transcripts representing Fch > 2 were chosen for validation. The differentiating status was confirmed for all of them: UTS2, UGT2B17 and SLC7A7. The mean expression of UTS2 was higher in CHB (25.8-fold change compared to CEU), while the expression of UGT2B17 and SLC7A7 was higher in CEU (3.2- and 2.2-fold change, respectively). In the next validation step, two transcripts were verified in the primary biological material. As an ultimate result of our study, two mRNA markers (UTS2 and UGT2B17) exhibiting population differences in the expression level in both B-cell line and in the blood were identified. Further statistical analysis confirmed the discriminatory potential of these two markers.

conclusionsAn inter-population differences on the level of gene expression were identified in both B-cell lines and peripheral blood samples. These findings may have a practical application in the field of forensic science. In particular, these transcripts, targeted by specific probes, may be used as population-specific targets in the efforts aiming to separate mixture of blood from individuals of different populations. Notwithstanding, these results have to be confirmed on extended population group.

Indexed as

TranscriptomeAsian PeopleBiomarkersCell LineForensic GeneticsGene Expression ProfilingHumansMaleMolecular TypingReal-Time Polymerase Chain ReactionSequence Analysis, RNAWhite PeopleBiomarkersClassifier testingDecision-treeGene expression studyHuman population identificationIllumina platformPopulation-specific mRNA markersTLDA cards

Identifiers

PMID30086702
PMCPMC6081795
OpenAlexW2885506740

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.